Why Covid-19 vaccination badly needs a global celebrity face
New Delhi– From the legendary Elvis Presley who became the global face of polio vaccination to superstar Amitabh Bachchan in India, celebrity endorsements have always helped vaccination rates go up, and now the hunt is on for a global face to support the Covid-19 vaccination in order to allay fears among people who either do not believe or are afraid to go in for the shot.
As the US prepares its nationwide vaccination programme, a new survey published in the American Journal of Infection Control has revealed that at least 21.3 per cent adults in the country are not planning to get the Covid-19 vaccine shot.
Covid-19: Over 50% of US citizens unwilling to get vaccinated under emergency authorisation
December 15, 2020
The study, Willingness to Get the Covid-19 Vaccine with and without Emergency Use Authorisation, is published in the American Journal of Infection Control. - REUTERS
The study, Willingness to Get the Covid-19 Vaccine with and without Emergency Use Authorisation, is published in the American Journal of Infection Control. - REUTERS×
The study finds that concerns about side effects were a significant barrier The first batch of Covid-19 vaccine has received emergency use authorisation in the United States. Yet the doubt whether US citizens are willing to get inoculated lingers.
New Study Assess Willingness to Get COVID-19 Vaccine by Angela Mohan on December 15, 2020 at 3:39 PM
New study assessed the psychological and social predictors of U.S. adults willingness to get COVID-19 vaccine and whether these predictors differ under an emergency use authorization release of the vaccine.
This study led by a Virginia Commonwealth University professor also assess whether these predictors differ under an emergency use authorization release of the vaccine.
The study, Willingness to Get the COVID-19 Vaccine with and without Emergency Use Authorization, will be published in the
American Journal of Infection Control.
It involved a survey of 788 U.S. adults, and found that 59.9% of respondents were definitely or probably planning to receive a future coronavirus vaccine, while 18.8% were neutral and 21.3% were probably or definitely not planning to get it.
Study examines psychological, social predictors of U.S. adults willingness to get COVID-19 vaccine
The first COVID-19 vaccine has received emergency use authorization. Yet a key question remains: Will U.S. adults be willing to get it?
A new study led by a Virginia Commonwealth University professor is among the first to examine the psychological and social predictors of U.S. adults willingness to get a future COVID-19 vaccine and whether these predictors differ under an emergency use authorization release of the vaccine.
The study, Willingness to Get the COVID-19 Vaccine with and without Emergency Use Authorization, will be published in the
E-Mail
RICHMOND, Va. (Dec. 14, 2020) The first COVID-19 vaccine has received emergency use authorization. Yet a key question remains: Will U.S. adults be willing to get it?
A new study led by a Virginia Commonwealth University professor is among the first to examine the psychological and social predictors of U.S. adults willingness to get a future COVID-19 vaccine and whether these predictors differ under an emergency use authorization release of the vaccine.
American Journal of Infection Control. It involved a survey of 788 U.S. adults, and found that 59.9% of respondents were definitely or probably planning to receive a future coronavirus vaccine, while 18.8% were neutral and 21.3% were probably or definitely not planning to get it.